Skip to main content

Advertisement

Log in

Role ofHelicobacter pylori in cirrhotic patients with peptic ulcer

A serological study

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Helicobacter pylori was found to be a promoter factor of peptic ulcer that has an incidence higher in patients with hepatic cirrhosis. To clarify the role betweenH. pylori and peptic ulcer in patients with hepatic cirrhosis, a serological test (ELISA test, HEL-p, AMRAD, Australia), was used to measure the presence ofH. pylori of patients with hepatic cirrhosis. Within two years, 108 cirrhotic patients who had received a panendoscopic examination were enrolled in this study. There were 79 males and 27 females with a mean age of 53.2 years. Sixty-four cases had positive serum HBsAg and 44 had negative serum. The results showed that the prevalence ofHelicobacter pylori in cirrhosis was 43.5% (47/108). There was no difference of HEL-p-positive rate between peptic ulcer and normal gastroduodenal mucosa (45.2% vs 46.1%,P>0.05). According to this study, there appears to be no relation between peptic ulcer andH. pylori in patients with hepatic cirrhosis. The etiology of peptic ulcer in cirrhotic patients need further study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Thiel von H: “Hepatogenic ulcer” theories and facts. Z Gastroenterol 16:73–84, 1978

    Google Scholar 

  2. Palmer ED, Brick IB: Sources of upper gastrointestinal hemorrhage in cirrhotic patients with esophageal varices. N Engl J Med 248:1057–1059, 1953

    Google Scholar 

  3. Sherlock S: Primary biliary cirrhosis (chronic intrahepatic obstruction jaundice). Gastroenterology 37:575–586, 1959

    Google Scholar 

  4. Tabaqchali S, Dawson AM: Peptic ulcer and gastric secretion in patients with liver disease. Gut 5:417–421, 1964

    Google Scholar 

  5. Mertz HR, Walsh JH: Peptic ulcer pathophysiology. Med Clin North Am 75:799–814, 1991

    Google Scholar 

  6. Marshall BJ:Campylobacter pylori: Its link to gastritis and peptic ulcer disease. Rev Infect Dis 12:S87-S98, 1990

    Google Scholar 

  7. Graham DY:Campylobacter pylori and peptic ulcer disease. Gastroenterology 96:615–625, 1989

    Google Scholar 

  8. Kirk AP, Dooley JS, Hunt RH: Peptic ulceration in patients with chronic liver disease. Dig Dis Sci 25:756–760, 1980

    Google Scholar 

  9. Sacchetti C, Capello M, Rebecchi P, Roncucci L, Zanchieri G, Tripodi A, De Leon MP: Frequency of upper gastrointestinal lesions in patients with liver cirrhosis. Dig Dis Sci 33:1218–1222, 1989

    Google Scholar 

  10. Sung JL, Wang TH, Chen CS, Lin PH, Chen CH: Epidemiological study on peptic ulcer and gastric cancer in the Chinese. J Formosa Med Assoc 75:116–119, 1976

    Google Scholar 

  11. Rauws EAJ, Langenberg W, Houthoff HJ, Zanen C, Tytgat GNJ:Campylobacter pyloridis-associated active chronic gastritis; a prospective study of its prevalence and the effects of antibacterial and anti-ulcer treatment. Gastroenterology 94:33–40, 1988

    Google Scholar 

  12. Barthel JS, Westblom TU, Havey AD, Gonzalez F, Everett ED: Gastritis andCampylobacter pylori in healthy, asymptomatic volunteers. Arch Intern Med 148:1149–1151, 1988

    Google Scholar 

  13. Pettross CW, Appleman MD, Cohen H, Valenzuela JE, Chandrasoma P, Laine LA: Prevalence ofCampylobacter pylori and association with antral mucosal histology in subjects with and without upper gastrointestinal symptoms. Dig Dis Sci 33:649–653, 1988

    Google Scholar 

  14. Perez-Perez GI, Dworkin B, Chodos J, Blaser MJ:Campylobacter pylori antibodies in humans. Ann Intern Med 109:11–17, 1988

    Google Scholar 

  15. Blaser MJ: Epidemiology and pathophysiology ofCampylobacter pylori infections. Rev Infect Dis 12:S99-S106, 1990

    Google Scholar 

  16. Hui WM, Lam SK, Chau PY, Ho-J, Lui I, Lai CL, Lok AS, Ng MMT: Persistence ofCampylobacter pyloridis despite healing of duodenal ulcer and improvement of accompanying duodenitis and gastritis. Dig Dis Sci 32:1255–1260, 1987

    Google Scholar 

  17. Borody TTJ, George LL, Brandl S, Andrews P, Ostapowics, Hyland L, Devine M:Helicobacter pylori-negative duodenal ulcer. Am J Gastroenterol 86:1154–1157, 1991

    Google Scholar 

  18. Nensey Y, Schubert TT, Bologna SD, Ma CK:Helicobacter pylori-negative duodenal ulcer. Am J Med 91:15–18, 1991

    Google Scholar 

  19. Sarfeh IJ, Tarnawski A, Malki A, Mason GR, Mach T, Ivey KJ: Portal hypertension and gastric mucosal injury in rats. Gastroenterology 84:987–993, 1983

    Google Scholar 

  20. Sarfeh IJ, Tarnawski A, Maeda R, Raymont K, Mason GR, Ivey KJ: The gastric mucosa in portal hypertension: Effects of topical bile acid. Scand J Gastroenterol 19(suppl 92):189–194, 1984

    Google Scholar 

  21. Sarfeh IJ, Tarnawski A, Hajduczek A, Stachura J, Bui HX: Does portal hypertension predispose gastric mucosa to aspirin injury? Histological, ultrastructural and functional analysis. Gastroenterology 92:A1614, 1987 (abstract)

    Google Scholar 

  22. Lin SK, Lambert JR, Schembri M, Nicholson L, Finlay M, Wong C, Coulepis A: A comparison of diagnostic tests to determineHelicobacter pylori infection. J Gastroenterol Hepatol 7:203–209, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, JJ., Changchien, CS., Tai, DI. et al. Role ofHelicobacter pylori in cirrhotic patients with peptic ulcer. Digest Dis Sci 39, 1565–1568 (1994). https://doi.org/10.1007/BF02088065

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02088065

Key words

Navigation